Back to top

Goldman Sachs Raises Price Target for AMLX to $20, Maintains Buy Rating | AMLX Stock News

Goldman Sachs Raises Price Target for AMLX to $20, Maintains Buy Rating | AMLX Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amylyx Pharmaceuticals, Inc. (AMLX)